Head-to-head for women
Gala Health vs Vytora Health
Gala Health and Vytora Health both offer GLP-1 telehealth to women, but they make different trade-offs on PCOS and hormonal suitability, clinical oversight, price and access. Here they are side-by-side on the Luna Fit Score — our women's-health rubric.
Gala Health
Ranked #17 for women · Grade B
Luna Fit
Best for: Women who want a low-cost compounded tirzepatide on-ramp nationwide, value having a brand-Ozempic escape hatch, and appreciate a provider that also treats the hormone side through its HRT and menopause line.
Visit Gala HealthVytora Health
Higher scoreRanked #5 for women · Grade B+
Luna Fit
Best for: Women who want the option of FDA-approved brand medication alongside compounded, from a LegitScript-accredited, all-50-states provider.
Visit Vytora HealthThe verdict for women
Vytora Health edges out Gala Health on the Luna Fit Score, 87 to 86 (B+ vs B). Women who want the option of FDA-approved brand medication alongside compounded, from a LegitScript-accredited, all-50-states provider.
Gala Health is still a genuine option — one of the lowest compounded-tirzepatide entry points we log — from $179, or $149 for a microdose — paired with a rare all-50-states footprint and an optional brand path. The adjacent HRT and menopause line is a genuine draw for women managing metabolism and hormones together. Weigh the six women's-health factors below against your own priorities.
Side-by-side on the six factors
Both providers scored on the same women's-health rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | Gala Health | Vytora Health |
|---|---|---|
| Luna Fit Score | 86/100 · B | 87/100 · B+ |
| Overall rank | #17 | #5 |
| Semaglutide | $1,299/mo | $150/mo |
| Tirzepatide | $179/mo | $200/mo |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Injection only | Injection only |
Luna Fit
Gala Health
Ranked #17 · Grade B
What we like
- Very low compounded entry — tirzepatide from $179, microdose from $149, three-month plans from $199
- Available across all 50 states — a rare full-nationwide footprint
- Offers a brand path (Ozempic) alongside compounded, so you aren't locked to one route
The caveats
- Compounded medication is not FDA-approved the way brand Ozempic or Zepbound are
- Brand-name access is very expensive — Ozempic runs about $1,299/mo
- No oral or sublingual route yet — injections only for the needle-averse
Luna Fit
Vytora Health
Ranked #5 · Grade B+
What we like
- Offers FDA-approved brand access as well as compounded — useful if you and your clinician want a name-brand path
- LegitScript-accredited, a meaningful third-party oversight signal when hormones are in play
- Nationwide across all 50 states, with tirzepatide at a reasonable $200
The caveats
- No oral/sublingual route for the needle-averse
- General metabolic program rather than a dedicated PCOS/hormone clinic
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Luna Fit Score. Pricing, states and verification reflect each provider's public disclosures at last review; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing Gala Health and Vytora Health against other providers we review for women.
- Gala Health vs CoreAge Rx
- Gala Health vs Eden
- Gala Health vs Ondra Health
- Vytora Health vs Found
- Vytora Health vs Effecty
- Vytora Health vs Vaylen
Or browse the full comparison hub.